ValuEngine cut shares of Trupanion (NASDAQ:TRUP) from a buy rating to a hold rating in a research report report published on Wednesday.
Other equities research analysts have also recently issued reports about the company. Lake Street Capital raised their target price on Trupanion from $32.00 to $41.00 and gave the company a buy rating in a research note on Wednesday, February 14th. Stifel Nicolaus reiterated a buy rating and issued a $34.00 target price (up from $33.00) on shares of Trupanion in a research note on Wednesday, February 14th. Northland Securities reiterated a buy rating and issued a $38.00 target price on shares of Trupanion in a research note on Thursday, February 8th. BidaskClub upgraded shares of Trupanion from a hold rating to a buy rating in a research note on Monday, December 18th. Finally, Zacks Investment Research upgraded shares of Trupanion from a hold rating to a buy rating and set a $37.00 price objective on the stock in a research note on Wednesday, November 8th. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company presently has a consensus rating of Buy and a consensus target price of $35.57.
Trupanion (TRUP) traded up $3.02 during mid-day trading on Wednesday, reaching $35.80. The company’s stock had a trading volume of 478,385 shares, compared to its average volume of 446,787. The company has a current ratio of 1.89, a quick ratio of 1.89 and a debt-to-equity ratio of 0.19. Trupanion has a 12 month low of $13.88 and a 12 month high of $36.88.
In related news, insider Darryl Rawlings sold 3,500 shares of Trupanion stock in a transaction dated Wednesday, December 27th. The shares were sold at an average price of $30.11, for a total transaction of $105,385.00. Following the sale, the insider now directly owns 1,389,976 shares in the company, valued at $41,852,177.36. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Murray B. Low sold 3,000 shares of Trupanion stock in a transaction dated Thursday, February 22nd. The shares were sold at an average price of $28.42, for a total transaction of $85,260.00. Following the sale, the director now owns 194,281 shares in the company, valued at $5,521,466.02. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,500 shares of company stock worth $635,005. Company insiders own 31.24% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Cambridge Investment Research Advisors Inc. bought a new stake in shares of Trupanion during the fourth quarter valued at about $494,000. MetLife Investment Advisors LLC acquired a new position in Trupanion during the fourth quarter worth about $324,000. PEAK6 Investments L.P. acquired a new position in Trupanion during the fourth quarter worth about $289,000. Millennium Management LLC acquired a new position in Trupanion during the fourth quarter worth about $6,851,000. Finally, Nine Ten Capital Management LLC grew its holdings in Trupanion by 0.7% during the fourth quarter. Nine Ten Capital Management LLC now owns 1,384,867 shares of the financial services provider’s stock worth $40,535,000 after acquiring an additional 9,900 shares during the period. Institutional investors and hedge funds own 74.75% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.themarketsdaily.com/2018/03/11/trupanion-trup-rating-lowered-to-hold-at-valuengine.html.
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.